Behavioral
Katherine J. Atkinson, MD, PC
Katherine J. Atkinson, MD, PC was paid $2.19M by Medicaid between Jan 2018 and Nov 2024, across 52 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 54% of everything it billed.
33Billing provider infoKATHERINE J. ATKINSON, MD, PC
AMHERST, MA 01002
AMHERST, MA 01002
33aNPI1568598993assigned 02/27/2007
33bProvider typeMental Health Counselor
28Total paid$2.19M
24GClaims39,731
24DCodes billed52
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Mental Health Counselor providers in Massachusetts
Rank by total paid#25 of 597
Median peer was paid$53K
This provider vs. median41×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,803 | $207K | |
| 2019 | 4,381 | $272K | |
| 2020 | 6,263 | $462K | |
| 2021 | 7,139 | $433K | |
| 2022 | 6,469 | $300K | |
| 2023 | 7,521 | $311K | |
| 2024incomplete | 4,155 | $202K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 54% | 16,438 | 11,512 | $1.17M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 17% | 3,727 | 2,475 | $378K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 6,339 | 5,686 | $352K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.4% | 536 | 533 | $54K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.2% | 1,023 | 976 | $26K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.1% | 1,437 | 536 | $25K |
| 90682 | <1% | 409 | 393 | $20K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,728 | 1,720 | $18K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 439 | 400 | $16K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 157 | 157 | $16K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 691 | 662 | $13K |
| 92587 | <1% | 1,604 | 860 | $13K |
40 more codes
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 237 | $11K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 318 | $9K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 211 | $7K |
| 96127 | <1% | 1,040 | $7K | |
| 91320 | <1% | 85 | $6K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 64 | $6K |
| 90686 | <1% | 638 | $5K | |
| 90480 | <1% | 131 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 131 | $4K |
| 0124A | <1% | 159 | $3K | |
| S3005 | Performance measurement, evaluation of patient self assessment, depression | <1% | 295 | $3K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 25 | $2K |
| 99173 | <1% | 86 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $2K |
| 90461 | <1% | 90 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 108 | $1K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 12 | $1K |
| 90837 | Psychotherapy session, about an hour | <1% | 72 | $1K |
| 80305 | <1% | 344 | $995.19 | |
| 0071A | <1% | 20 | $917.40 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 70 | $913.22 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 100 | $880.03 |
| 98940 | <1% | 41 | $864.59 | |
| 80306 | <1% | 160 | $701.51 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 30 | $679.85 |
| 97124 | <1% | 40 | $572.80 | |
| 0011A | <1% | 24 | $530.44 | |
| 92551 | <1% | 47 | $456.03 | |
| 0012A | <1% | 14 | $454.24 | |
| 99490 | Ccm add 20min | <1% | 29 | $178.89 |
| 81003 | <1% | 54 | $91.51 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 51 | $76.59 |
| 91312 | 0% | 159 | $0.00 | |
| A4617 | Mouth piece | 0% | 16 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 12 | $0.00 |
| 99000 | 0% | 140 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 58 | $0.00 |
| 91301 | 0% | 45 | $0.00 | |
| 91307 | 0% | 23 | $0.00 | |
| 90694 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUPTA, PIYUSH (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Caremore Medical Associates PLLC | Fort Worth, TX | $189K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.